DrugPatentWatch Database Preview
Risdiplam - Generic Drug Details
What are the generic drug sources for risdiplam and what is the scope of patent protection?
Risdiplam
is the generic ingredient in one branded drug marketed by Genentech Inc and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.Risdiplam has eighty-seven patent family members in thirty-three countries.
One supplier is listed for this compound.
Summary for risdiplam
| International Patents: | 87 |
| US Patents: | 2 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 21 |
| Clinical Trials: | 10 |
| Patent Applications: | 28 |
| What excipients (inactive ingredients) are in risdiplam? | risdiplam excipients list |
| DailyMed Link: | risdiplam at DailyMed |
Recent Clinical Trials for risdiplam
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Biogen | Phase 3 |
| Hoffmann-La Roche | Phase 2 |
| Hoffmann-La Roche | Phase 2/Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for risdiplam
US Patents and Regulatory Information for risdiplam
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech Inc | EVRYSDI | risdiplam | FOR SOLUTION;ORAL | 213535-001 | Aug 7, 2020 | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | Y | Y | ⤷ Try it Free | ||
| Genentech Inc | EVRYSDI | risdiplam | FOR SOLUTION;ORAL | 213535-001 | Aug 7, 2020 | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | ||||
| Genentech Inc | EVRYSDI | risdiplam | FOR SOLUTION;ORAL | 213535-001 | Aug 7, 2020 | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | Y | Y | ⤷ Try it Free | ||
| Genentech Inc | EVRYSDI | risdiplam | FOR SOLUTION;ORAL | 213535-001 | Aug 7, 2020 | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for risdiplam
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Morocco | 51988 | ⤷ Try it Free |
| European Patent Office | 3143025 | ⤷ Try it Free |
| Singapore | 11201404713P | ⤷ Try it Free |
| Turkey | 201813877 | ⤷ Try it Free |
| Singapore | 10201609188W | ⤷ Try it Free |
| Taiwan | 201336842 | ⤷ Try it Free |
| South Korea | 20200093066 | ⤷ Try it Free |
| >Country | >Patent Number | >Estimated Expiration |
